Blog

World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML

5 Sep 2025, 2:56 p.m. in Global Stories, News & Statements by T1International

Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits

7 Aug 2025, 8:27 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International

T1International statement regarding largest cuts to healthcare coverage in American History.

3 Jul 2025, 8:45 p.m. in #insulin4all USA, News & Statements by T1International

The recently passed “One Big Beautiful Bill” represents the largest and greatest healthcare loss in American history, cutting health care for 17 million people living in this country. This bill, passed in the United States Congress today, is a profound and deadly cut for people living with diabetes, their families, and marginalized and disabled people across the country.
Read more

"I Wasn’t a ‘Bad Diabetic.’ I Just Couldn’t Afford Insulin."

11 Jun 2025, 5:06 p.m. in #insulin4all USA by Lacy McGee

Findings from T1International's 2024 Out-of-Pocket Expenses and Rationing Survey

28 May 2025, 4:15 p.m. in #insulin4all USA, Global Stories by T1International

T1International at the United Nations Multi-stakeholder hearing on NCDs and Mental Health

5 May 2025, 7:52 p.m. in News & Statements by T1International

On May 2, 2025, #insulin4all advocates, including T1International’s Executive Director Shaina Kasper, participated in a high-level United Nations hearing to shape the agenda for the upcoming Political Declaration on noncommunicable diseases. In remarks, Kasper called on UN member states to urgently address insulin affordability, support public manufacturing, and center patients in global diabetes policy decisions. Emphasizing that the insulin crisis is far from over, she highlighted patient stories from around the world and urged bold action to ensure equitable access to lifesaving diabetes care. Read more